| Tag | Content |
|---|
EnhancerAtlas ID | HS149-01103 |
Organism | Homo sapiens |
Tissue/cell | NKC |
Coordinate | chr7:150452000-150454020 |
Target genes | | Number: 13 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CDX2 | MA0465.1 | chr7:150453291-150453302 | TTTTATGGCTC | - | 6.14 | | IRF1 | MA0050.2 | chr7:150452508-150452529 | GAAGAGAAAATGAAAGAAAAC | - | 7.59 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_16262 | chr7:150451964-150454091 | CD4_Naive_Primary_7pool | | SE_17582 | chr7:150426529-150454636 | CD4p_CD25-_CD45RAp_Naive | | SE_18426 | chr7:150426462-150454963 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr7 | 150452024 | 150453675 | | chr7 | 150452624 | 150452940 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH07I150753 | chr7 | 150450289 | 150454641 |
|
Enhancer Sequence | TTTAAGATGG AAACTACTTC CATCAAGTGG AGTGGTATAG TCAACAACAA AAGGCAATGG 60
GAATAAAATG AGATTGAAAT CAAAAGATGA ATTTTCAGCC TGTCCTTCAA AGACTATCCC 120
CTACCTTCTG TGGAAGACCA GGGTGGGGGA AGGATGTTCA GGTGATCTTT CCTTGCCCTG 180
CAATTTGTGG GGAAGCCATA TGTGTACCCA CATAGAGGGT GCAGCAGCCA CTATGTGCAT 240
ATATGAAAAT GCTCTTGCAC AAACACAAGA AATGAGCTCA TCAGTATCAC CATAGGGGTA 300
CCATCTGAGC TCATTCTATT CCAGACTTTA GGTTCTTAAA AATATAATAT CAGTCATATT 360
TTCAGTTAGC ACATATCTGG GACTTTAGGG TATATGATTT TTTCTCCTAA TTCAGGAATA 420
AAGAAACTGA GGTTTAGAAA GATCAAGTGT CTTGTCCACG CTGGCACAGA CTGTTACTGG 480
TAGAACTGGG GGGTCGGGGT GGGGGAGAGA AGAGAAAATG AAAGAAAACA AAACAAGCCT 540
TGTTATCTGC CAGGTCCTGG AATTTCTTGC AAGGTCTACA GATGGCCTAG GAGCAACCCT 600
CCCTCTCCTA GGCAGTCTCT CTCACTGTCT TATAGGCTCT TTATAAAAAC ACAAGAGCAA 660
TGAGACATGA TGAACCTGGC CACAAATTTG GTCTGCTAGA GAGAGAGAGA GAGAGAGAGA 720
GAGGGACCAT ATCCCTGGGG ACAGGAAAAT AACAATGTGT GTGGGTTTCC GTACAAAGCC 780
GCCCTCAGAG GGTGACTCAA GGCCCTGAGA GACAGCCAGG GTAAGAAGCT GTTTGTAAAA 840
CAGCTCTGCT TCCTTTTTCC CACCACACCT CTGTGATGCT TTTGTGCAAA ACAAACTTTT 900
TACCAGAATT AGCAGGAGCA CTGAGACCCG GAAAAGCCAC TAAACATCTG AATATGGCTG 960
CATCCCAGGG AAGGCCAACA GCTGCCTGTT ACTGGCCCAG GCTGGACATA TACACATCTC 1020
CCAGCCACCA TCTGCAGTGC GCCATAAAGA GAGTTTCTTA TTTTTGTTGT TTTTTTTTTT 1080
GAGAAATGGG GTCTCCCTAT GTTGCCCAGG CTAGTCTTGA ACTCCTGAGC TCAAGTGATA 1140
CACCTGCTTC AGCCTCCCAA AGTGCTGGGA TTATAGGCAT GAGCCTGGCC AAGAGAGTTT 1200
CCTATATTGA ATTCTAGATG GCAGTGAGGA CTGAACCCAA GGGCACTCTC CAGGTTCCAC 1260
TGCACAAGGA GCAGGCATCT TTCTTGAAAC ATTTTATGGC TCCCTCTTAC TTCTGCCAAA 1320
TGCCCTGCCC TCAGGTTACC TGTGCTCTGA CCTGAGGGGG AGGCAAGGCT TAGGAGATTT 1380
CCCCACCCAG GAGGATTTCA TTTCCGCAGG GACCAGGAAG ACATCTGACC CCATTCATGA 1440
TGTGATTTAG CCAAAGTGAC AAGCCCTTGA CAAGTTAACA AGGGGCTCGG GAGAAGGGAA 1500
GAGGGTGGCC CCGGTCATGC TGGGAGCCTC TGTGTTGTGG TGGTGGGTGC AGGGGGAGTG 1560
GGCAGAGCTC CTCTCTGGGG ACTTTCTCAG GTGAATGAGG CAGAGCTTGA TCAGTTACTT 1620
GCACATTTGC ATTTAGATGG ATTCAGTTTT TAAAGAAATT ATAAGCCAGA GAGTGAGATA 1680
CAGGTGACTC CTGATTCTTT GATTTAGTTT GGAGAGGAGG GCGGTTCTAA CGCAGATAAC 1740
ATATACAGTT CGCACTTTGC AATGAAAGCC AGATTTGACT TCCAAAATAT TCTCTCATAT 1800
TAATATTGTA ATGTTCACTT TTCATATAAT AACAGTTATA ACTTTCCCTC TCTAAAAGTC 1860
TGTAGAATTA TGGTGGTTTC ATTTCAAAAT GTGTTTTCCT AACAGTGAGA TGTAAATAGA 1920
AATCTGGTAA TTCCTAACAG GACTAAATTC TTATAAGATT TTTTGGACAA ATCTAAAGGG 1980
AATCACTGAT ATGTCTCTCT CCTACCACAG ACATGCAGGT 2020
|
